Dost Ongur, PhD, MD

The New Emphasis on Community Functioning in Schizophrenia

February 1, 2015

Dost Ongur, PhD, MD and Daniel Carlat, MD

Dost Ongur, PhD, MD Chief, Psychotic Disorders Division, McLean Hospital, Belmont, MA Associate Professor of Psychiatry, Harvard Medical School Dr. Ongur has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity. Daniel Carlat, MD Editor-in-Chief, Publisher, The Carlat Report. Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

Learn about the new emphasis on community functioning for patients with schizophrenia, in an interview with Dost Ongur, MD, PhD, chief of the psychotic disorders division at McLean Hospital and an associate professor of psychiatry at Harvard Medical School.

Topics in the Treatment of Schizophrenia

December 1, 2009

Dost Ongur, PhD, MD

TCPR-December-2009-Tx-Schizophrenia_DostOngurMD_headshot.png

Dost Ongur, MD. Clinical Director, Schizophrenia and Bipolar Disorder Program, McLean Hospital
Assistant Professor of Psychiatry , Harvard Medical School
Dr. Ongur has disclosed that he has received free study medication (Riluzole) from Sanofi Aventis for a study on bipolar depres-
sion. Dr. Carlat has found that there is no evidence of commercial bias in this educational activity.

Dr. Ongur, over the past few decades, the dominant theory of schizophrenia has been the dopamine hypothesis, but that has been changing lately. Can give us a quick review of the original hypothesis and then go on to some of the alternative neurochemical theories?